The human double-stranded (ds) RNA-binding protein Staufen (hStau) is considered to have a role in RNA transport and its localization. By using sedimentation analysis on sucrose gradients, we showed that the Staufen isoform with an apparent molecular mass of 55 kDa (Stau&&) co-fractionated with ribosomes and associated with both the 40 and 60 S ribosomal subunits, suggesting that the Staufen isoform hStau&& plays some role in translation. To map the determinant(s) involved in this association, we generated a series of deletion mutants and analysed their subcellular distribution by cell fractionation and fluorescent immunomicroscopy. Our results demonstrated that multiple determinants promote hStau&&-ribosome association via both an RNA-binding-dependent mechanism and protein-protein interaction. The RNA-binding activity of the ds
INTRODUCTION
Mammalian Staufen, an RNA-binding protein, binds to RNAs and double-stranded (ds) RNAs with extensive secondary structures [1, 2] . Staufen contains four copies of a ds RNA-binding protein domain (dsRBD) consensus sequence. Molecular dissection of the protein in itro revealed that only one of them, dsRBD3, efficiently binds to ds RNA, although dsRBD4 has a weak RNA-binding activity [2] . Mammalian Staufen was also shown to bind tubulin in itro, via a tubulin-binding domain similar to the MAP-1B microtubule-binding domain [2] . Electron microscopy and pharmacological studies in rat hippocampal neurons were consistent with the idea that Staufen associates with microtubules, but direct interaction in i o has not been described previously [3] [4] [5] . In both neurons and fibroblasts, Staufen co-localizes mainly with markers of the rough endoplasmic reticulum (RER) [1] [2] [3] . Cell fractionation and sedimentation analyses before and after dissociation of polyribosomes by puromycin or EDTA treatment further suggested that Staufen co-fractionated with ribosomes and polysomes [1] . Interestingly, endogenous and transfected Staufen were shown to co-localize with SYTO 14-labelled granules in dendrites of hippocampal neurons in culture [3, 4] . SYTO 14-labelled granules were shown to correspond to clusters of ribosomes and to colocalize with polyadenylated [poly(A) + ] RNAs, the 60 S ribosomal subunit and the translation elongation factor 1α [6] . Recently [7] , these densely packed clusters of ribosomes were shown to be highly enriched in Staufen protein. Therefore we hypothesized that Staufen-ribosome association observed by biochemical analyses is relevant for in i o Staufen function.
Staufen isoforms with apparent molecular masses of 55 kDa (Stau&&) and 63\65 kDa (Stau'$) have been observed by Western blotting in human, mouse and rat. cDNAs coding for Stau&& have been isolated in these species [1] [2] [3] 5] . In a previous study, we
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RNA-binding protein domain 3 (dsRBD3) but not that of dsRBD4 is the first determinant. Although necessary for stable association with ribosomes, dsRBD3 alone is not sufficient and needs other determinants as co-factors. Consistently, when expressed together, dsRBD4 and the tubulin-binding domain constitute the minimal Stau&&\ribosome protein-protein association domain. This region of Stau&& is sufficient to associate with ribosomes independently, but requires the RNA-binding activity of dsRBD3 for complete association. Thus the results are consistent with a putative role for Stau&& in the regulation of translation.
reported a differentially spliced transcript in human cells that codes for a protein of 63 kDa and co-migrates with the 63 kDa protein revealed by the Western-blot analysis [2] . Since similar differentially spliced transcripts have not been found in the mouse and rat [5, 8] , it is possible that the cloned transcript is specifically expressed in humans and the 63\65 kDa isoform represents a third isoform for which a cDNA has not been isolated so far in any species.
In Drosophila sp., Staufen was shown to be involved in the transport and localization of specific mRNAs in oocytes and neuroblasts [9] and also essential for the derepression of oskar mRNA, once localized at the posterior pole [10] . The role of Staufen in mammals is still unclear. Human ds RNA-binding protein Staufen (hStau) was shown to be a component of RNAcontaining granules that migrates in the dendrites of hippocampal neurons [4] . Also, it was shown to be encapsulated along with the HIV-1 RNA into virus particles [11] , which strongly suggests an involvement in mRNA transport. In addition, its association with clusters of ribosomes in moving granules supports the hypothesis that it can be involved in translation regulation [7] .
In the present study, we used multiple biochemical and cellular techniques to show that the Staufen isoform hStau&& is associated with ribosomes. To understand the mechanism by which it associates with ribosomes, we have also studied the subcellular distribution of a series of hStau&& mutants expressed in trans. These experiments allowed us to identify the molecular requirements for Stau&&-ribosome association.
EXPERIMENTAL

Cell culture and microscopy
Mammalian cells grown in Dulbecco's modified Eagle's medium supplemented with 10 % foetal bovine serum, and penicillin- streptomycin were transiently transfected with cDNAs using the calcium phosphate precipitation technique. Cells were fixed less than 16 h post-transfection to prevent overexpression of the proteins and stained with antibodies as described previously [2] . For the analysis of cytoskeleton-associated proteins, transfected cells were first extracted in 0.3 % (v\v) Triton X-100 before fixation. Cells were revealed by immunofluorescence using the i63 Plan-Apochromat objective of a Zeiss Axioskop fluorescence microscope.
Construction and molecular cloning of the fusion proteins
All mutants were constructed by PCR amplification of the cDNAs coding for hStau&& using the Vent DNA polymerase (New England Biolabs, Beverly, MA, U.S.A.). The resulting fragments were digested with appropriate restriction enzymes and cloned in pCDNA3\rous sarcoma virus [12] . When necessary, a haemagglutinin (HA) tag, namely HA $ , or the green fluorescent protein (GFP) was added to the C-terminus of the mutants as described previously [2] . Primers used for PCR amplification are listed in Table 1 . For hStau&&∆4 and hStau&&∆3, the PCR was treated with DpnI (Roche Molecular Biochemicals, Laval, Quebec, Canada) and T4 PNK kinase (Pharmacia, Baie d'Urfe! , Quebec, Canada) before being self-ligated and cloned.
Phenylalanine residues at position 135 in dsRBD3 and at position 238 in dsRBD4 were mutated into alanine residues [Phe"$& Ala (F135A), Phe#$) Ala (F238A)] using two sense primers with mutations and an antisense primer located downstream from the endogenous EcoRI-restriction site ( Table 1) . The resulting fragments were digested with Sma I-EcoRI and Stu I-EcoRI respectively, substituted for the corresponding wildtype fragment in hStau&& cDNA and then sequenced.
All the fusion and mutated proteins were first expressed in COS7 cells and analysed by SDS\PAGE to test their level of expression and stability. We fixed or harvested the cells 16 h post-transfection to prevent overexpression of the proteins in subsequent studies. At this time point, the amount of transfected proteins is usually less than that of the endogenous Stau&& protein (right-hand side panels in the Figures). The half-life of wild-type and of several mutants has been described previously [11] .
Protein purification, Western blotting and RNA-binding assay
To determine the RNA-binding capacity of hStau&&\3* and hStau&&\3*\4*, we substituted the HA $ tag with a His' tag at the C-terminal end of the mutants by using the annealed oligonucleotides 5h-GGCCACCATCACCATCACCATTA-3h and 5h-GGCCTAATGGTGATGGTGATGGT-3h. After transfection into HEK-293 cells, the cells were harvested and lysed. hStau&&-His' fusion proteins were isolated on Ni# + -nitrilotriacetate (Ni-NTA) columns as described previously [2] . Expression of the mutants was determined by Western blotting. Their RNA-binding capacity was determined by Northwestern blotting as described previously [2] .
Cell fractionation on sucrose gradients
Cell fractionation was done by sedimentation analysis on sucrose gradients [13] . COS7 cells were rinsed with cold (4 mC) PBS (pH 7.5), and harvested. Approximately 4i10( cells were resuspended in 3 ml of lysis buffer [10 mM Hepes (pH 7.5), 12.5 % sucrose, 1 mM EDTA, 1 mM PMSF, 1 µg\ml pepstatin, 1 µg\ml aprotinin] and were subjected to at least 10 strokes in a Dounce homogenizer. Two centrifugations at 700 g and 1000 g were performed and the resulting supernatant was layered on to a step gradient containing nine fractions of 22-60 % (w\v) sucrose in 10 mM Hepes (pH 7.5) and 1 mM MgCl # . The gradients were centrifuged at 37 000 rev.\min (SW41 rotor ; Beckman Instruments, Spinco Division, Palo Alto, CA, U.S.A.) for 2.5 h at 4 mC. Fifteen fractions (0.77 ml) were taken sequentially from the top of the tube and aliquots of each fraction were analysed by SDS\ PAGE. Proteins were transferred on to a nitrocellulose mem-brane and probed with anti-HA, anti-hStau [2] , anti-calnexin (Stressgene, BC, Canada), anti-ribosomal L7a or anti-α-tubulin antibodies (ICN Biomedicals, Irvine, CA, U.S.A.). Quantification of the protein amounts that co-fractionated with ribosomes, RER or soluble proteins was done with an HP ScanJet (6100C) using the NIH image processing and analysis program.
For ribosome analysis, COS7 cells were washed in cold (4 mC) PBS (pH 7.5), and in an isotonic buffer [110 mM potassium acetate\2 mM MgCl # \1 mM dithiothreitol (DTT)\10 mM Hepes (pH 7.5)]. Cells were recovered with a rubber policeman in a hypotonic buffer [10 mM potassium acetate\25 mM EDTA\ 1 mM DTT\5 mM Hepes (pH 7.5)], supplemented with 1 unit\ml RNase inhibitors (Applied Biosystems, Foster City, CA, U.S.A.) and EDTA-free ' complete ' protease inhibitor cocktail (Roche, Indianapolis, IN, U.S.A.). Cells were broken by two sets of 20 strokes in a 23-gauge syringe followed by centrifugation at 1500 g for 10 min. Supernatants were pooled, adjusted to 100 mM KCl and 0.5 % Nonidet P40. Extracts were left on ice for 30 min and centrifuged on a continuous 10-40 % sucrose gradient containing 100 mM KCl, 10 mM potassium acetate, 25 mM EDTA, 1 mM DTT and 5 mM Hepes (pH 7.5) for 4 h at 38 000 rev.\ min in a SW41 rotor. Fractions (0.8 ml) were recovered and the RNA sedimentation profile was monitored spectrophotometrically at 254 nm. Total RNA was prepared from the fractions by phenol-chloroform extraction and ethanol precipitation and RNA was separated on denaturing formaldehyde-agarose gel. Proteins were recovered by acetone precipitation and analysed by Western blotting. Images were obtained on a Bio-Rad PhosphorImager.
Co-immunoprecipitation
Transfected cells were washed in isotonic buffer and the extracts were prepared as described above for the ribosomal gradient. Immunoprecipitations were performed with the anti-ribosomal P protein human antiserum as described previously [14] .
RESULTS
Stau
-HA 3 is associated with ribosomes
To determine the subcellular localization of Stau&& in COS7 cells and also to determine whether transfected hStau&&-HA $ has the same distribution and therefore can be used to map the determinant(s) involved in Staufen distribution, we compared their sedimentation profile in a 22-60 % sucrose gradient. Transfected cells were harvested about 16 h post-transfection to prevent overexpression of the protein. Each fraction of the gradient was analysed by Western blotting with anti-hStau, anti-HA, anticalnexin, anti-L7a and anti-α-tubulin antibodies to detect endogenous Stau&&, transfected hStau&&-HA $ , RER, ribosomes and soluble proteins respectively. As shown in Figure 1(A) , endogenous Stau&& in untransfected cells was found predominantly in ribosome-containing fractions like L7a. The cloned hStau&&-HA $ presented a similar profile and also co-fractionated with ribosomes ( Figure 1B ).
To confirm that the endogenous Stau&& and hStau&&-HA $ are associated with ribosomes and to separate the ribosome subunits, COS7 cell extracts were separated in a sharper sucrose gradient (10-40 %) and subjected to a longer centrifugation time in the presence of EDTA. Under these conditions, the co-migration of endogenous Stau&& (Figure 2A ) and hStau&&-HA $ ( Figure 2B ) with both the 40 and 60 S ribosomal subunits demonstrated their association with ribosomes. Altogether, these results indicate that Stau&& is associated with ribosomes, which transiently express hStau&&-HA $ , has the same subcellular distribution as the en- dogenous protein, and that it can be used to identify the molecular determinant(s) involved in Stau&&-ribosome association.
Staufen RNA-binding activity is one of the determinants for ribosome association
As hStau&& contains a strong dsRBD3 and a weak dsRBD4, is RNA-binding activity involved in hStau&&-ribosome association? To find an answer, we introduced point mutations in dsRBD3 alone (F135A) or in both dsRBD3 (F135A) and dsRBD4 (F238A) to generate hStau&&\3*-His' and hStau&&\3*\4*-His' (Figure 3) . We first tested whether the point mutations introduced in the dsRBDs eliminated the ds RNA-binding capacity of the protein. hStau&&-His', hStau&&\3*-His' and hStau&&\3*\4*-His' were expressed in mammalian cells and purified on the Ni-NTA columns. Levels of expression were determined by Western blotting ( Figure 4A ) and RNA-binding activity by Northwesternblot assay ( Figure 4B ). This experiment showed that the mutations are sufficient to eliminate the ds RNA-binding capacity of the mutants and that dsRBD3 is critical for this activity.
Analysis of transiently transfected COS7 cells by immunofluorescence showed that hStau&&\3*-HA $ and hStau&&\3*\4*-HA $ were randomly distributed in the cells, which demonstrated that RNA-binding activity was essential for their stable association with cell structures. However, when the cells were treated with Triton X-100 before fixation to remove the soluble proteins, significant amounts were retained in Triton-resistant structures (results not shown). Consistently, when analysed by sucrose density centrifugation, more than 35 % of both hStau&&\ 3*\4*-HA $ ( Figure 4C ) and hStau&&\3*-HA $ ( Figure 4D ) were found along with the soluble proteins, as compared with 3 % for hStau&&-HA $ . Approximately 50 % of both proteins still cofractionated with the ribosome marker. A similar point mutation that eliminated the weak RNA-binding activity of dsRBD4 alone (hStau&&\4*-HA $ ) had no effect on its distribution ( Figure 4E ), which is similar to that of hStau&&-HA $ . These results indicate that dsRBD3 RNA-binding activity plays a role(s) in the subcellular localization of hStau&&, especially on the amount and strength of hStau&&-ribosome association. However, it did not completely eliminate the co-fractionation of the protein with ribosomes, which implies that protein-protein interaction also occurs.
dsRBD4/TBD is necessary and sufficient for protein-protein interaction with ribosomes
We mapped the minimal domain that is required for hStau&&\ribosome protein-protein interaction. When expressed alone, dsRBD2-GFP, dsRBD3-GFP (results not shown), dsRBD4-GFP ( Figure 5 , upper panels) and TBD-GFP [2] were . IF : j, complete association with subcellular organelles/structures in the absence or presence of Triton X-100 ; k, random cytosolic/nuclear distribution before Triton treatment and complete protein removal after Triton treatment ; j/k, random cytosolic/nuclear distribution before Triton treatment but significant association with subcellular organelles/structures after Triton treatment. Gradients : j, cofractionation of Staufen with ribosomes ; j/k, co-fractionation with ribosomes and with soluble proteins ; k, lack of co-fractionation with ribosomes.
both randomly distributed in the cell and extracted by Triton X-100. Consistently, none of the dsRBD2-HA $ , dsRBD3-HA $ , dsRBD4-HA $ or TBD-HA $ co-fractionated with ribosomes in the sucrose gradients (results not shown). However, when dsRBD4 and TBD were fused together, large amounts of RBD4\TBD-GFP were retained with the Triton X-100-insoluble materials ( Figure 5 , lower panels). RBD4\TBD-HA $ also cofractionated with ribosomes in the sucrose gradient ( Figure 6A ). Approximately 35 % of RBD4\TBD-HA $ was found in the fractions with soluble proteins, as described above for hStau&&\3*\4*-HA $ . When the F238A point mutation was introduced in dsRBD4 to generate RBD4*\TBD-HA $ , both immunofluorescence analyses in the presence or absence of Triton X-100 (results not shown) and cell fractionation ( Figure  6B ) indicated that the mutation that eliminated the RNA-binding activity of dsRBD4 had no effect on the RBD4*\TBD-HA $ distribution, when compared with that of RBD4\TBD-HA $ . In contrast, TBD\5-HA $ was shown to be randomly distributed and completely removed by Triton treatment in transfected cells (results not shown), and was found in the fractions containing soluble proteins in the sucrose gradient (results not shown). These results demonstrate that the region encompassing dsRBD4\TBD is necessary and sufficient for the localization of Staufen to ribosomes through protein-protein interaction and constitutes the minimal RNA-independent ribosome-binding domain. How- The fusion proteins were electrophoresed on a 10 % polyacrylamide gel, transferred on to the nitrocellulose membrane and incubated with 32 P-labelled bicoid 3huntranslated region RNA as described previously [2] . After extensive washing, RNA binding was detected by autoradiography. COS7 were transfected with hStau 55 /3*/4*-HA 3 (C), hStau 55 /3*-HA 3 (D) or hStau 55 /4*-HA 3 (E) and fractionated on the sucrose gradient. Each fraction was collected and the proteins were separated by SDS/PAGE and analysed as described in ever, this region is not capable of providing full association as observed with hStau&&-HA $ .
RNA-binding-dependent and -independent Stau 55 -ribosome association
To confirm these results and study the relationship between the RNA-binding-dependent and -independent mechanisms, we deleted dsRBD4 from the full-length protein as a possible way to eliminate Stau&&\ribosome protein-protein interaction. An additional mutant was constructed in which the deletion was paired with a point mutation in dsRBD3 that abolished its RNA- binding activity. As controls, we also deleted dsRBD3 and dsRBD5 to generate hStau&&∆3-HA $ and hStau&&∆5-HA $ (Figure 3) . Each mutant was transfected in COS7 cells and their phenotype as hStau&&\3*-HA $ (see Figures 7A and 4D ) ; significant amount of the protein was found with soluble proteins but approx. 50 % of hStau&&∆3-HA $ was able to get associated with ribosomes. Deletion of dsRBD5 (hStau&&∆5-HA $ ) had no effect on hStau&& distribution, which still co-fractionated with ribosomes ( Figure 7B ). Therefore dsRBD5 is not involved in the Stau&&\ribosome protein-protein interaction.
Deletion of dsRBD4 from hStau&& (hStau&&∆4-HA $ ) only had a minor effect on the strong ribosome association of the protein ( Figure 8A ). However, when deletion of dsRBD4 was paired to a point mutation in dsRBD3 that eliminated Stau&& RNA-binding activity, hStau&&\3*\∆4-HA $ showed random cytoplasmic\ nuclear distribution by immunofluorescence (results not shown) and co-fractionated with soluble proteins in the gradient ( Figure  8B ). Therefore hStau&&∆4-HA $ associates with ribosomes only via an RNA-binding-dependent mechanism in contrast with hStau&&-HA $ , which relies on both RNA-binding activity and protein-protein interaction. Results obtained with these two mutants confirm that RNA-binding activity is involved in the Stau&&-HA $ \ribosome association and that dsRBD4, but not its weak RNA-binding activity (cf. hStau&&\3*\4*-HA $ with hStau&&\3*\∆4-HA $ ), plays a significant role in the hStau&&\ ribosome protein-protein interaction.
hStau 55 -HA 3 
and dsRBD4/TBD co-immonoprecipitate with ribosomes
To acquire further evidence that hStau&& and RBD4\TBD are bound to ribosomes, we immunoprecipitated ribosomes and tested for their presence in the immunoprecipitates. Therefore hStau&&-HA $ , RBD4\TBD-HA $ and TBD\5-HA $ , used as controls, were expressed in the COS7 cells. Transfected cell extracts were immunoprecipitated with anti-human ribosome antibody. Immunoprecipitates were analysed by Western blotting with anti-L7a (used as control) and anti-HA ( Figure 9A ) antibody to monitor ribosome precipitation and test putative co-immunoprecipitation of HA-tagged proteins respectively. As expected from Figures 2 and 6 , both hStau&&-HA $ ( Figure 9A , lane 8) and RBD4\TBD-HA $ ( Figure 9A , lane 7) were detected in the immunoprecipitates, whereas TBD\5-HA $ was not ( Figure 9A , lane 6). The reverse experiment confirmed the Stau&&-ribosome association ( Figure 9B ). When cell extracts were immunoprecipitated with anti-Staufen antibody, the ribosomal P protein was detected in the resulting immunoprecipitate by Western blotting. Used as controls, normal human serum ( Figure 9A ) and rabbit pre-immune serum ( Figure 9B ) were unable to coimmunoprecipitate Stau&&-HA $ , RBD4\TBD-HA $ and ribosomal proteins respectively. Altogether, these results further confirm Staufens' presence in a complex with ribosomes and that RBD4\TBD is capable of performing the RNA-independent interaction.
DISCUSSION
Stau
is associated with ribosomes
It was previously suggested that Staufen is involved in mRNA transport in neurons [4, 5, 15] . This suggestion was based on the fact that Staufen-GFP-labelled granules move from the cell body to the dendrites in a microtubule-dependent manner. [1] [2] [3] . Therefore we propose that Stau&& is involved in a ribosomerelated function. Since Stau&& is ubiquitously expressed in mammals, it may be involved in a general pathway of translation and regulation. This is unlikely, because the number of Stau&& molecules within a cell is far less than that of the ribosomes. Stau&& only defines a very small population of ribosomes and therefore should not have an impact on translation of most of the mRNA. Alternatively, Stau&& may define a functional subpopulation of ribosomes, e.g. those recruited for RNA localization, which is a phenomenon described in every cell type but more easily established in neurons. In neurons, Staufen was described in RNA granules, consisting of densely packed clusters of ribosomes [7] . These authors hypothesized that Stau&& may play an important role in a dynamic and multi-step pathway involved in the transport of translationally silent RNA granules and transfer of specific mRNAs to active polysomes after cell activation. Genetic studies involving oskar mRNA and Staufen in Drosophila sp. [10] are consistent with the possibility that Staufen modulates translation. It will be interesting to determine whether Stau&& is involved in the derepression of mRNA translation as that of its Drosophila sp. homologue [16] or whether it plays other role(s).
Several members of the ds RNA-binding protein family, such as the ds RNA-dependent protein kinase (PKR), the Xenopus lae is RNA-binding protein A, the TAR-RNA-binding protein and NF90, were also shown to bind the ribosomes [17] [18] [19] [20] . The molecular mechanism for ribosome association may be similar between members of the family since association of PKR with ribosomes involves both the presence of functional dsRBDs and an additional RNA-independent ribosome-association site [19, 20] . Therefore Stau&& may compete for ribosome-binding sites or modulate the function(s) of other ribosome-bound members of the dsRBP family. Heterodimer formation between members of the family has been described previously [21, 22] .
Ribosome association through dsRBD3 and protein-protein interaction
Our analyses of mutants demonstrated that dsRBD3 is the major RNA-binding domain and one of the molecular determinants for Stau&& association with ribosomes. A point mutation in the conserved phenylalanine residue was shown to eliminate the RNA-binding activity of both Drosophila sp. Staufen and mammalian PKR dsRBDs [23] [24] [25] [26] [27] and also to disrupt the dsRBD3 RNA-binding activity of Stau&&. This mutation also impaired Stau&& association with ribosomes and had the same phenotype as the one with the complete deletion of dsRBD3, suggesting that the RNA-binding activity of dsRBD3 is crucial for ribosome association. In contrast, the weak RNA-binding activity of dsRBD4 observed in itro is not necessary for these functions. Indeed, dsRBD4 seems to contribute very little, if any, to the RNA-binding activity of the full-length protein in i o. Interestingly, the K64E (Lys'% Glu) point mutation in PKR dsRBD1 also impaired both RNA-binding activity and PKRribosome association [19] . This lysine residue was shown to be present at the RNA-protein interface, where it interacted with the ds RNA [28, 29] , and its mutation did not modify the structure of the domain, adopting the same conformation as that of the wild-type protein [28] . Altogether, these results suggest that RNA-binding activity plays some role in the ribosome association by members of the dsRBP family. Alternatively, we do not exclude the possibility that protein-protein interaction mediated by dsRBD3 is involved in ribosome association. A point mutation in dsRBD1 of PKR that eliminates the RNAbinding activity of the protein was also shown to abolish PKR interaction with the 60 S ribosomal protein L18, which suggests that L18 and ds RNA compete for the dsRBD1-binding site [30] .
If Stau&& RNA-binding activity is indeed required as a molecular determinant for the ribosome association, what is the RNA target ? One possibility is that Stau&& directly binds to ribosomal RNA. This would be consistent with the fact that Stau&& binds to both ribosomal subunits as shown in the present study and that the NMR solution structure of Drosophila sp. dsRBD3 shares many features common to the N-terminal domain of the bacterial ribosomal RNA-binding protein S5 [23] . If bound to ribosomal RNA, Stau&& may not be directly linked with the mRNAs. Alternatively, Stau&& may bind to mRNAs and this binding may trigger a conformational switch in Stau&& that unmasks the protein-protein determinant.
Our results also demonstrated that dsRBD4\TBD is responsible for the protein-protein interaction of Stau&&. Proteinprotein interactions mediated by dsRBDs have been described for Drosophila sp. Staufen and other members of the ds RNA-binding protein family [22, [31] [32] [33] . Similarly, the region of Drosophila sp. Staufen that corresponds to the mammalian TBD was shown to bind inscuteable [31] , a cytoskeletal adaptor. TBD in hStau&& binds to tubulin in itro [2] , and both the distribution [3] and the movement [4] of Stau&&-containing ribosome clusters within dendrites of neurons in culture are sensitive to drugs that disrupt microtubules. Since ribosomes are also associated with the cytoskeleton [34] , it is possible that hStau&& binding to ribosomes involves previous or simultaneous association with the microtubule network via TBD. Altogether, the results are consistent with the hypothesis that the ds RNAbinding domain dsRBD3 interacts with ribosomal RNA, whereas dsRBD4\TBD interacts with a separate site on the ribosome through protein-protein interaction. Further studies should determine the relative affinity of each determinant for ribosome association and identify the ribosomal or ribosome-associated RNA and protein partners required for interaction.
